| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $230K | +1.0% | -75.1% |
| Cost of Revenue | $145K | -32.0% | -82.9% |
| R&D Expense | $2.5M | -11.7% | -42.6% |
| SG&A Expense | $2.3M | -21.7% | -58.3% |
| Operating Income | -$4.7M | +18.1% | +51.1% |
| Pre-tax Income | -$1.2M | +72.2% | +88.6% |
| Net Income | -$984K | +75.9% | +90.3% |
| EPS (Basic) | -$0.02 | +77.8% | +98.6% |
| EPS (Diluted) | -$0.02 | +77.8% | +98.6% |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $582K | +11.7% | -87.2% |
| Short-term Investments | $19K | — | -92.3% |
| Accounts Receivable | $180K | +617.9% | -11.4% |
| Inventory | $203K | -0.1% | +16.2% |
| Current Assets | $2.1M | +40.8% | -66.8% |
| Total Assets | $20.8M | -3.7% |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$9.7M | — | — |
| Capital Expenditures | $58K | — | — |
| Investing Cash Flow | $58K | — | — |
| Financing Cash Flow | $9.2M | — | — |
| Free Cash Flow | -$9.8M | — | — |
| -55.4% |
| Current Liabilities | $22.2M | -4.6% | +114.8% |
| Total Liabilities | $27.7M | -5.9% | +26.2% |
| Stockholders' Equity | -$1.3M | +46.5% | -104.6% |